Key facts
- It has raised $660K; the latest was Angel (individual) ($660K) in Dec 2025.
- Notable investors include Yianni Charalambous.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for HP-1
- ·The full record, as it builds
Funding rounds
No funding rounds for HP-1 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HP-1
Provider of a supplement intended to increase focus and mental performance. The company offers a science-backed supplement powered by creatine, caffeine, and other synergistic ingredients, enabling students, working professionals, athletes, and creators to enhance clarity, boost cognitive function, and support well-being to get the job done.
- Sector
- Consumer Products and Services (B2C)
- HQ
- England, United Kingdom
- Founded
- 2025
- Employees
- 7
- Website
- hp-1.com/
- Ownership
- Privately Held (backing)
HP-1 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HP-1 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HP-1 in its N-PORT filings yet. We sweep new filings monthly.